🇺🇸 FDA

Intelligence · Patent portfolio

PTC THERAPEUTICS Patents

Full USPTO pharma patent portfolio for PTC THERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
149
Expiring ≤24m
3

Quick answer

PTC THERAPEUTICS has 149 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 10618877

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10584115

    Substituted pyridine and pyrazine BMI-1 inhibitors

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10555960

    Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10517853

    Methods for treating epilepsy

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10501482

    Compounds for treating spinal muscular atrophy

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10428050

    Substituted reverse pyrimidine Bmi-1 inhibitors

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10370371

    Substituted pyrimidine Bmi-1 inhibitors

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10300047

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10285980

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10233161

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10195202

    Methods for modulating the amount of RNA transcripts

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10172836

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10034863

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10028939

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9975878

    Substituted triazine BMI-1 inhibitors

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9969754

    Compounds for treating spinal muscular atrophy

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9914722

    Compounds for treating spinal muscular atrophy

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9879007

    Compounds for treating spinal muscular atrophy

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9877952

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9873677

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9737513

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9650395

    Antibacterial compounds and methods for use

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9617268

    Compounds for treating spinal muscular atrophy

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9593108

    Compounds and methods for antiviral treatment

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9586955

    Compounds for treating spinal muscular atrophy

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9522137

    Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9493845

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9474743

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9409905

    Antibacterial compounds and methods for use

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9399649

    Compounds for treating spinal muscular atrophy

    Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9371336

    Compounds for treating spinal muscular atrophy

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9351964

    Methods for treating cancer and non-neoplastic conditions

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9315467

    Compounds for nonsense suppression, and methods for their use

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9309206

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9289398

    Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9273076

    Compounds for nonsense suppression, and methods for their use

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9271960

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9226919

    Methods for dosing an orally active 1,2,4-oxadiazole

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9198907

    Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9051342

    Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8986935

    Methods for treating spinal muscular atrophy

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8975287

    Methods for using 1,2,4-Oxadiazole benzoic acid compounds

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8946444

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8940896

    Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does PTC THERAPEUTICS have?

149 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do PTC THERAPEUTICS patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.